Literature DB >> 12800536

Perioperative management of patients undergoing pituitary surgery.

Mary Lee Vance1.   

Abstract

The management of a patient who requires pituitary surgery should be a constant collaboration between the neurosurgeon and the endocrinologist. Because the pituitary gland is an anatomic and functional entity, both medical specialties are necessary to treat these patients for the best possible outcome. The notion that pituitary surgery is always curative is not accurate because of the risk for tumor recurrence. A patient with a pituitary lesion who undergoes surgery is clinically identical to a patient with diabetes mellitus--these patients require lifelong monitoring and management as indicated by the clinical, endocrine and anatomic findings. Because there is always a risk for tumor recurrence, appropriate surgical or radiation treatment and hormone replacement may be required at any time after the initial operation. In the patient who undergoes postoperative pituitary radiation, the risk for developing a new pituitary hormone deficiency ranges from 33% to 50%, and is probably higher over time. Thus, these patients must receive regular evaluations regarding the need for additional treatment and hormone replacements. A regular program of life long assessment of pituitary function and anatomy, appropriate hormone replacement and close collaboration with a pituitary surgeon is the ideal care of these patients. Only with such a program can a patient with a pituitary adenoma achieve the best possible outcome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12800536     DOI: 10.1016/s0889-8529(03)00003-3

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  8 in total

1.  Clinical features of nonpituitary sellar lesions in a large surgical series.

Authors:  Elena Valassi; Beverly M K Biller; Anne Klibanski; Brooke Swearingen
Journal:  Clin Endocrinol (Oxf)       Date:  2010-12       Impact factor: 3.478

2.  OUTCOME OF IMPLEMENTATION OF A MULTIDISCIPLINARY TEAM APPROACH TO THE CARE OF PATIENTS AFTER TRANSSPHENOIDAL SURGERY.

Authors:  Arthur S Carminucci; John C Ausiello; Gabrielle Page-Wilson; Michelle Lee; Laura Good; Jeffrey N Bruce; Pamela U Freda
Journal:  Endocr Pract       Date:  2015-10-05       Impact factor: 3.443

3.  Transsphenoidal Surgery of Giant Pituitary Adenoma: Results and Experience of 239 Cases in A Single Center.

Authors:  Yike Chen; Xiaohui Xu; Jing Cao; Yuanqing Jie; Linkai Wang; Feng Cai; Sheng Chen; Wei Yan; Yuan Hong; Jianmin Zhang; Qun Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-06       Impact factor: 6.055

4.  Preoperative assessment of adult patients for intracranial surgery.

Authors:  Vanitha Sivanaser; Pirjo Manninen
Journal:  Anesthesiol Res Pract       Date:  2010-03-31

Review 5.  Postoperative assessment of the patient after transsphenoidal pituitary surgery.

Authors:  John C Ausiello; Jeffrey N Bruce; Pamela U Freda
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

6.  Downregulation of Insulin-like growth factor binding protein 6 is associated with ACTH-secreting pituitary adenoma growth.

Authors:  Yakun Yang; Miaomiao Sheng; Fengming Huang; Dechao Bu; Xiaohai Liu; Yong Yao; Congxin Dai; Bowen Sun; Jindong Zhu; Yonghui Jiao; Zhenqing Wei; Huijuan Zhu; Lin Lu; Yi Zhao; Chengyu Jiang; Renzhi Wang
Journal:  Pituitary       Date:  2014-12       Impact factor: 4.107

7.  Perioperative glucose control in neurosurgical patients.

Authors:  Daniel Agustín Godoy; Mario Di Napoli; Alberto Biestro; Rainer Lenhardt
Journal:  Anesthesiol Res Pract       Date:  2012-02-13

8.  Radiographic pituitary stalk disruption: A rare sequela of secondary empty sella syndrome.

Authors:  Evan Winograd; Michael W Kortz; Kevin O Lillehei
Journal:  Surg Neurol Int       Date:  2021-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.